Telerehabilitation for Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 21, 2020

Primary Completion Date

June 15, 2021

Study Completion Date

June 15, 2021

Conditions
Parkinson DiseaseTelemedicine
Interventions
OTHER

Physical and occupational therapy (PT/OT)

"Neurologic-specialized and -certified physical and occupational therapists will provide each participant with an initial in-person PT/OT evaluation/treatment session with oversight from a Movement Disorders Neurologist, followed by 4 virtual home visits with tele-PT/OT and care partner supervision every 2 weeks, and culminating with a final in-person evaluation, all with a focus on personalized training in core areas contributing to a patient's individual fall risk, much like in-person visits. Virtual home safety surveillance with the mobile virtual platform is an additional feature of this intervention that aims to optimize the home environment to reduce external factors contributing to fall risk."

OTHER

Home Safety Evaluation (HSE)

The VIRTUAL HOME SAFETY EVALUTIONS (HSE)-ONLY ARM where participants ONLY receive the virtual home safety evaluations and surveillance that are built into the original protocol of three of the four tele-OT visits that is being used in Arm 1. The study duration for Arm 2 is about 6 weeks of the primary intervention as described with 3-month and 6-month follow-up calls. The mobile virtual platform for Arm 2 is comprised of a tablet OR smartphone that will be guided through the home by the care partner only and not the patient.

Trial Locations (1)

60612

Rush University Medical Center, Chicago

All Listed Sponsors
lead

Rush University Medical Center

OTHER

NCT04600011 - Telerehabilitation for Parkinson's Disease | Biotech Hunter | Biotech Hunter